US Edition
Published • loading... • Updated
Nektar Therapeutics to Participate in Two Investor Conferences in March
Summary by Helena Independent Record
13 Articles
13 Articles
The Toronto Star+3 Reposted by 3 other sources
Axsome Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor…
·Toronto, Canada
Read Full Article
Montana Standard+8 Reposted by 8 other sources
Nektar Therapeutics to Participate in Two Investor Conferences in March
SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be participating in the TD Cowen 46th Annual Health Care Conference taking place March 2-4, 2026 in Boston and the 2026 Jefferies Biotech…
Coverage Details
Total News Sources13
Leaning Left3Leaning Right0Center7Last UpdatedBias Distribution70% Center
Bias Distribution
- 70% of the sources are Center
70% Center
L 30%
C 70%
Factuality
To view factuality data please Upgrade to Premium
